# BCG Vaccine for Health Care Workers as Defense Against COVID 19

> **NCT04348370** · PHASE4 · COMPLETED · sponsor: **Texas A&M University** · enrollment: 659 (actual)

## Conditions studied

- Coronavirus
- Coronavirus Infection
- Coronavirus as the Cause of Diseases Classified Elsewhere

## Interventions

- **BIOLOGICAL:** BCG Vaccine
- **BIOLOGICAL:** Placebo Vaccine

## Key facts

- **NCT ID:** NCT04348370
- **Lead sponsor:** Texas A&M University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-20
- **Primary completion:** 2023-04-21
- **Final completion:** 2023-04-21
- **Target enrollment:** 659 (ACTUAL)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04348370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04348370, "BCG Vaccine for Health Care Workers as Defense Against COVID 19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04348370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*